BeyondSpring Inc. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BeyondSpring Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $570.00K, a 304.26% increase year-over-year.
- BeyondSpring Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-03-31 was $459.00K, a 92.86% increase year-over-year.
- BeyondSpring Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $163.00K, a 80.36% decline year-over-year.
- BeyondSpring Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-06-30 was $141.00K, a 81.83% decline year-over-year.
- BeyondSpring Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $724.00K, a 68.08% decline from fiscal 2024.
- BeyondSpring Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $2.27M, a 193.02% increase from fiscal 2023.
- BeyondSpring Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $774.00K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $570.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $459.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $724.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $163.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $141.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $238.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $2.27M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $830.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $776.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $241.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $774.00K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $1.66M 20-F · filed 2023-04-18 | |
| 2021-12-31 | -$1.88M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $3.28M 20-F · filed 2023-04-18 |
| 2021-09-30 | $1.58M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | |
| 2020-12-31 | $2.10M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $8.17M 20-F · filed 2023-04-18 |
| 2020-09-30 | $1.76M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | |
| 2020-06-30 | $836.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | |
| 2020-03-31 | $3.47M 6-K · filed 2020-06-11 | |
| 2019-12-31 | $2.10M 20-F · filed 2022-04-14 | |
| 2018-12-31 | $519.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $6.56M 20-F · filed 2021-04-30 |
| 2018-09-30 | $848.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18 | |
| 2018-06-30 | $992.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-09-18 | |
| 2018-03-31 | $4.20M 6-K · filed 2019-07-10 | |
| 2017-12-31 | $22.68M 20-F · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |